Day: July 29, 2020

Net revenues of $895.8 million, increased 11.9% with the year-ago quarter, were the Company’s third highest quarterly net revenues.Record Institutional Group net revenues and fixed income brokerage revenues.Net income available to common shareholders of $103.0 million, or $1.39 per diluted common share.Non-GAAP net income available to common shareholders of $115.3 million, or $1.55 per diluted common share.Annualized return on average tangible common shareholders’ equity (1) was 20.7%.Non-GAAP annualized return on average tangible common shareholders’ equity (1) was 23.2%.ST. LOUIS, July 29, 2020 (GLOBE NEWSWIRE) — Stifel Financial Corp. (NYSE: SF) today reported net income available to common shareholders of $103.0 million, or $1.39 per diluted common share on net revenues of $895.8 million for the three months ended June 30, 2020,...

NEW YORK, NY, July 29, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — iQSTEL Inc. (OTC: IQST), a leading-edge 21st Century Enhanced Telecommunications Service Provider, is pleased to provide the latest figures from Q2 2020 for our operating subsidiaries.iQSTEL’s overall revenues for Q2 2020 surpassed the $11M mark and the net income broke past the $420K mark. The company continues on track to reach further record revenues/income figures as well as new acquisitions throughout the rest of 2020.As seen in the included spreadsheet image (full details in the forthcoming Q2 filing), our operating subsidiaries all had positive Net Income:“The tremendous growth we have seen in 2020 continues despite COVID-19’s global economic impact. Further proof that our business model, a combination of corporate growth and acquisitions, is working...

MARSEILLE, France, July 29, 2020 (GLOBE NEWSWIRE) — Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”) today announced the publication of a Nature paper entitled, “Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis,” authored by Innate researchers in partnership with scientists from Hôpitaux Universitaires de Marseille AP-HM (La Timone and North Hospitals), Laveran Hospital, Aix Marseille University, the Centre d’Immunologie de Marseille-Luminy (Inserm, CNRS, AMU) and Marseille Immunopole/AP-HM immunoprofiling laboratory at La Timone Hospital. This Marseille-based exploratory research taskforce, named EXPLORE COVID-19, analyzed immune cells in COVID-19 patients at different stages of the disease. The goal of the study was to gain translational insights to...

New research suggests targeting C5a-C5aR1 axis could limit severe inflammatory responseInnate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”) today announced the publication of a Nature paper entitled, “Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis,” authored by Innate researchers in partnership with scientists from Hôpitaux Universitaires de Marseille AP-HM (La Timone and North Hospitals), Laveran Hospital, Aix Marseille University, the Centre d’Immunologie de Marseille-Luminy (Inserm, CNRS, AMU) and Marseille Immunopole/AP-HM immunoprofiling laboratory at La Timone Hospital. This Marseille-based exploratory research taskforce, named EXPLORE COVID-19, analyzed immune cells in COVID-19 patients at different stages of the disease. The goal of the study was to gain...

Les données suggèrent que le ciblage de la voie C5a-C5aR1 pourrait limiter la réponse inflammatoire sévèreInnate Pharma SA (Euronext Paris : IPH – ISIN : FR0010331421 ; Nasdaq : IPHA) (« Innate » ou la « Société ») a annoncé la publication d’un article dans la revue scientifique Nature, intitulé « Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis »[*], écrit par les chercheurs d’Innate en collaboration avec les Hôpitaux Universitaires de Marseille – AP-HM (Hôpital de la Timone et Hôpital Nord), l’Hôpital Laveran, l’Université Aix-Marseille (AMU), le Centre d’Immunologie de Marseille-Luminy (Inserm, CNRS, AMU) ainsi que le laboratoire d’immunoprofiling de Marseille Immunopôle / AP-HM à l’Hôpital de la Timone.Cette task-force de recherche exploratoire marseillaise, baptisée EXPLORE COVID-19, a...

  Fondsbørsmeddelelse nr. 13/2020 cBrain er valgt som leverandør på den nationale franske rammeaftaleKøbenhavn, 29. juli 2020cBrain er kommet på listen over leverandører hos UGAP, Union des Groupements d’Achats Publics. UGAP er en offentlig myndighed under det franske økonomi- og finansministerium, som understøtter offentlige indkøb, herunder bl.a. en rammeaftale for indkøb af software.Det er et vigtigt skridt for cBrain i Frankrig, at selskabet nu er kommet på UGAP’s rammeaftale.cBrain udbyder F2 på rammeaftalen i form af et serviceabonnement, ofte kaldt software-as-a-service. På rammeaftalen udbyder cBrain endvidere de forskellige typer af konsulentydelser, som kan være relevante i forbindelse med anskaffelse og ibrugtagning af F2, herunder konfigurering af standardsoftwaren, undervisning af brugere og support. Konsulentydelser...

Press ReleaseOoredoo Qatar’s 5G commercial services go live with Nokia cloud-native 5G core networkNokia cloud-native 5G core network allows Ooredoo Qatar to deliver a wide breadth of commercial 5G services to its retail and enterprise users This milestone reaffirms Ooredoo Qatar’s commitment to transforming network assets to cloud-native technology29 July 2020Espoo, Finland – Nokia has today announced that Ooredoo Qatar has launched a Nokia-powered cloud-native core network for commercial 5G services, allowing the operator to provide superior mobile broadband services to its roughly two million subscribers in Qatar.The new core network facilitates automation for improved network efficiency and streamlined network management. The transformation of the core network also enables Ooredoo Qatar to bring new and exciting use cases such as...

AKVA group ASA hereby invites you to the presentation of the Q2 and H1 2020 financial results, which will take place as follows:Time: Friday 14 August 2020 at 10:00 CETPlace: Danske Bank, Bryggetorget 4, 0250 Oslo   Limitations based on National guidelines from the Norwegian Directorate of Health relating to Covid-19 will apply.The event will also be available as webcast. A link to the webcast will be made available at a later date on AKVA groups website; https://ir.akvagroup.com/investor-relations/financial-information.  A recorded version of the presentation will also be available after the live stream is concluded.The presentation will be held in English and is open to all interested parties.Dated: 29 July 2020AKVA group ASAWeb: www.akvagroup.comCONTACTS:This information is subject to the disclosure requirements pursuant to Section...

Higher profit despite partial business closures in Western EuropeSecond quarter 2020Net turnover amounted to SEK 6,777 M (7,426), a decrease of 9 per cent.Operational earnings amounted to SEK 335 M (306).The improvement was attributable to the Service Business in Sweden and Norway. Performance in Western Europe was adversely impacted by partial business closures due to COVID-19 restrictions. Profit for the period amounted to SEK 213 M (203) and earnings per share to SEK 2.15 (2.05).Operating cash flow amounted to SEK 1,471 M (337) and was positively affected by significantly lower stock.First six months 2020Net turnover amounted to SEK 14,227 M (14,300).Operational earnings amounted to SEK 614 M (544).Profit for the period amounted to SEK 380 M (357) and earnings per share to SEK 3.80 (3.55).Operating cash flow amounted to SEK 1,729 M...

Högre resultat trots delvis stängd verksamhet i VästeuropaAndra kvartalet 2020Nettoomsättningen uppgick till 6 777 Mkr (7 426), en minskning med 9 procent.Operativt rörelseresultat uppgick till 335 Mkr (306).Resultatförbättringen var hänförlig till Serviceaffären i Sverige och Norge. Resultatet i Västeuropa påverkades negativt av delvis stängd verksamhet på grund av Covid-19 restriktioner.  Periodens resultat uppgick till 213 Mkr (203) och resultat per aktie till 2,15 kronor (2,05).Operativt kassaflöde uppgick till 1 471 Mkr (337) och påverkades positivt av väsentligt lägre varulager.Första halvåret 2020Nettoomsättningen uppgick till 14 227 Mkr (14 300).Operativt rörelseresultat uppgick till 614 Mkr (544).Periodens resultat uppgick till 380 Mkr (357) och resultat per aktie till 3,80 kronor (3,55).Operativt kassaflöde uppgick till 1 729...